alexa Sudha Srivastava | Tata Institute of Fundamental Resear
ISSN: 1948-5964

Journal of Antivirals & Antiretrovirals
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Sudha Srivastava

Sudha Srivastava Sudha Srivastava
National Facility for High Field NMR
Tata Institute of Fundamental Research
India
Tel. 91-222-278-2377
Read Interview session with Sudha Srivastava
Biography

Sudha Srivastava National Facility for High Field NMR Tata Institute of Fundamental Research, Mumbai, India.

Research Interest

NMR & Spectroscopic Methods.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Conformation of the Antigenic Peptide Tyrosinase (192-200) in Water and DMSO-d6 by NMR Spectroscopy and MD Simulations
Evans C Coutinho, Mishra NB, Deep Bhattacharya, Sudha Srivastava, Mamata Joshi and Mushtaque Shaikh
Commentary: Pharm Anal Acta 2015, 6: 392
DOI: 10.4172/2153-2435.1000392
 
Conformational Study on Pheromonotropin neuropeptide using NMR and Molecular Dynamics
Deep Bhattacharya, Nitin Mishra, Evans C Coutinho, Sudha Srivastava, Raghuvir RS Pissurlenkar and Mushtaque Shaikh
Commentary: Pharm Anal Acta 2015, 6: 359
DOI: 10.4172/2153-2435.1000359
 
Amino Coated Gold Nanorods Based Amperometric Glucose Detection
Shikha Sharma, Navendu Goswami, Nidhi Gupta and Sudha Srivastava
Research Article: Int J Adv Tech
 
To Probe the Conformational Adaptability of Conserved G-P-G-R Segment in the V3 Loop of HIV-1
Sudha Srivastava and Meena Kanyalkar
Research Article: J Antivir Antiretrovir 2012, 4: 088
 

Journal of Antivirals & Antiretrovirals - Novel Inhibitor by Modifying Oseltamivir Based on Neuraminidase Structure for Treating Drug-Resistant H5N1 Virus Using Molecular Docking NMR and DSC Methods


Novel Inhibitor by Modifying Oseltamivir Based on Neuraminidase Structure for Treating Drug-Resistant H5N1 Virus Using Molecular Docking NMR and DSC Methods

Presented by: Sudha Srivastava
National Facility for High Field NMR
Tata Institute of Fundamental Research
India

 
Download PPT PPT Views: 185 Updated on: 2015-10-19 For Recent Update: Click here
 
 
Download PDF   PDF Views: 185  Updated on: 2015-10-19 For Recent Update: Click here
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords